Novakivskyy, V. (2017). PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION. Ukrainian Journal of Nephrology and Dialysis, (1(53), 26-31. https://doi.org/10.31450/ukrjnd.1(53).2017.04